$8.55
In chiusura: Oct 6 EDT
$8.36
-0.19-2.22%
Pre-mercato: 5:34 AM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
4D Molecular Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 12
Stima EPS
$-1.000
Stima dei ricavi trimestrali
$645.80K
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$33.00K
Analizza lo storico degli utili di 4D Molecular Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
FDMT | 4D Molecular Therapeutics | -$0.79 | -$1.00 | — | — | $3.00K | $645.80K | — | — | 11/12/2025 | |
FDMT | 4D Molecular Therapeutics | -$0.63 | -$0.77 | -$0.98 | -27.27% | $5.00K | $737.68K | $15.00K | -97.97% | 08/11/2025 | |
FDMT | 4D Molecular Therapeutics | -$0.66 | -$0.86 | -$0.86 | 0.00% | $28.00K | $529.67K | $14.00K | -97.36% | 05/08/2025 | |
FDMT | 4D Molecular Therapeutics | -$0.77 | -$0.83 | -$0.90 | -8.43% | -$17.00K | $2.20M | $1.00K | -99.95% | 02/28/2025 | |
FDMT | 4D Molecular Therapeutics | -$0.24 | -$0.70 | -$0.79 | -12.86% | $20.20K | $560.00K | $3.00K | -99.46% | 11/13/2024 | |
FDMT | 4D Molecular Therapeutics | -$0.77 | -$0.71 | -$0.63 | 11.27% | $239.00K | — | $5.00K | — | 08/08/2024 | |
FDMT | 4D Molecular Therapeutics | -$0.88 | -$0.74 | -$0.66 | 10.81% | $298.00K | $780.00K | $28.00K | -96.41% | 05/09/2024 | |
FDMT | 4D Molecular Therapeutics | -$0.84 | -$0.74 | -$0.77 | -4.05% | $1.25M | $2.06M | -$17.00K | -100.83% | 02/29/2024 | |
FDMT | 4D Molecular Therapeutics | -$0.79 | -$0.54 | -$0.24 | 55.56% | $500.00K | $9.87M | $20.20M | 104.70% | 11/09/2023 | |
FDMT | 4D Molecular Therapeutics | -$0.87 | -$0.81 | -$0.77 | 4.94% | $162.00K | $850.00K | $239.00K | -71.88% | 08/09/2023 | |
FDMT | 4D Molecular Therapeutics | -$0.82 | -$0.90 | -$0.88 | 2.22% | $1.22M | $1.03M | $298.00K | -71.07% | 05/10/2023 | |
FDMT | 4D Molecular Therapeutics | -$0.85 | -$0.79 | -$0.84 | -6.33% | $92.00K | $3.01M | $1.25M | -58.57% | 03/15/2023 | |
FDMT | 4D Molecular Therapeutics | -$0.82 | -$0.91 | -$0.79 | 13.19% | $1.37M | — | $500.00K | — | 11/08/2022 | |
FDMT | 4D Molecular Therapeutics | -$0.28 | -$0.85 | -$0.87 | -2.35% | $14.58M | $860.00K | $162.00K | -81.16% | 08/11/2022 | |
FDMT | 4D Molecular Therapeutics | -$0.61 | — | -$0.82 | — | $2.00M | — | $1.22M | — | 05/12/2022 | |
FDMT | 4D Molecular Therapeutics | — | -$0.86 | -$0.85 | 1.16% | — | — | $92.00K | — | 03/28/2022 | |
FDMT | 4D Molecular Therapeutics | -$1.51 | -$0.80 | -$0.82 | -2.50% | $7.42M | $170.00K | $1.37M | 703.53% | 11/10/2021 | |
FDMT | 4D Molecular Therapeutics | -$2.92 | -$0.68 | -$0.28 | 58.82% | $3.63M | $14.58M | $14.58M | 0.00% | 08/12/2021 | |
FDMT | 4D Molecular Therapeutics | -$2.54 | -$1.17 | -$0.61 | 47.86% | $3.50M | — | $2.00M | — | 05/13/2021 |
4D Molecular Therapeutics (FDMT) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $-0.98 | $-0.77 | -27.3 % |
| Q1 | 2025-05-08 | $-0.86 | $-0.86 | 0.00 % |
| Q4 | 2025-02-28 | $-0.90 | $-0.83 | -8.43 % |
| Q3 | 2024-11-13 | $-0.79 | $-0.70 | -12.9 % |
4D Molecular Therapeutics (FDMT) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $15.00K | $737.68K | -98.0 % |
| Q1 | 2025-05-08 | $14.00K | $529.67K | -97.4 % |
| Q4 | 2025-02-28 | $1.00K | $2.20M | -100.0 % |
| Q3 | 2024-11-13 | $3.00K | $560.00K | -99.5 % |
FAQ
Quando 4D Molecular Therapeutics (NASDAQ:FDMT) riporterà gli utili?
Si prevede che 4D Molecular Therapeutics (FDMT) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 11, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di 4D Molecular Therapeutics (NASDAQ:FDMT)?
L'EPS effettivo era $-0.98, che mancato la stima di $-0.77.
Quali sono state le entrate di 4D Molecular Therapeutics (NASDAQ:FDMT)?
Le entrate effettive sono state $15K, che mancato la stima di $737.7K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.